Long‐term Efficacy and Safety of Bexarotene for Japanese Patients With Cutaneous T‐cell Lymphoma: The Results of a Phase 2 Study (B‐1201)

Journal of Dermatology - United States
doi 10.1111/1346-8138.14923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma

2012English

Ten-Year Experience of Bexarotene Therapy for Cutaneous T-Cell Lymphoma in Finland

Acta Dermato-Venereologica
DermatologyMedicine
2012English

Bianca: A Phase 2 Study of the Safety and Efficacy of Tisagenlecleucel in Pediatric Patients With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Long-Term Safety and Efficacy of the Novel Β3 -Adrenoreceptor Agonist Vibegron in Japanese Patients With Overactive Bladder: A Phase III Prospective Study

International Journal of Urology
Urology
2018English

Long-Term Clinical Efficacy and Safety of Secukinumab for Japanese Patients With Psoriasis: A Single-Center Experience

Journal of Dermatology
DermatologyMedicine
2017English

Menus for Managing Patients With Cutaneous T-Cell Lymphoma

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2012English

Portia: A Phase 1b Study Evaluating Safety and Efficacy of Tisagenlecleucel and Pembrolizumab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary
EndocrinologyMetabolismDiabetes
2019English

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy